London markets are bracing for a busy day of corporate updates on Wednesday, as three major US-listed companies — ASML, Morgan Stanley and Johnson & Johnson — release their latest quarterly results. The trio’s reports are expected to influence sentiment across the FTSE 100, particularly in the technology, financial and healthcare sectors, which together account for a significant portion of the index’s weight.
ASML, the Dutch semiconductor equipment giant, is seen as a key indicator for the global chip industry. Its earnings will be scrutinised for any signs of slowing demand from chipmakers, especially amid ongoing geopolitical tensions over export controls. A miss could weigh on London-listed tech stocks such as Sage Group and Aveva, while a beat might lift the broader sector.
Morgan Stanley’s results will be parsed for clues on the health of investment banking fees and wealth management revenues. UK banks including Barclays, HSBC and Lloyds often move in sympathy with US peers, and any weakness in trading income or advisory fees could ripple across the FTSE 350 financials index. Analysts at Citi have noted that US bank earnings so far this season have been mixed, with consumer lending showing resilience but dealmaking remaining subdued.
Johnson & Johnson’s update will provide a window into consumer health and pharmaceutical demand, areas that directly affect UK-listed peers such as Reckitt Benckiser and Haleon. The company’s outlook on medical device sales and patent expirations could also influence sentiment in the wider healthcare sector, which represents roughly 12% of the FTSE 100 by market capitalisation.
For UK investors and pension holders, these results matter because they help set the tone for global equity markets. The FTSE 100 has been trading within a narrow range in recent sessions, with the index closing at 8,124 on Tuesday, down 0.3% on the day. A strong showing from these three companies could provide a catalyst for a rally, while disappointments may deepen the current cautious mood.